Ad Code: 26102

BVA-Guided Treatment Improves Hospital LOS & Outcomes For a study, John Strobeck, MD, PhD, and colleagues analyzed data on 245 consecutive HF admissions to a community hospital for whom total blood volume (TBV), red blood...

SGLT2 inhibitors cut the risk for cardiovascular death and HF hospitalization in patients with HF, according to a study published in The Lancet. Muthiah Vaduganathan, MD, and colleagues reviewed data from 12,251 participants....

For patients with HF, homebased palliative care reduced risk for in-hospital death, according to a study published in CMAJ. Kieran L. Quinn, MD, PhD, and colleagues examined whether collaborative palliative care was associated...

Patients with acute decompensated HF were randomized to receive standard loop diuretics with the addition of either acetazolamide (500 mg IV;N=259) or placebo (N=256) for the ADVOR study. At randomization, oral loop diuretics...

New research was presented at ESC 2022, the annual European Society of Cardiology Congress. The features below highlight some of the studies that emerged from the conference. Dapagliflozin DELIVERs for HFmrEF/HFpEF The phase 3...

BVA-Guided Treatment Improves Hospital LOS & Outcomes For a study, John Strobeck, MD, PhD, and colleagues analyzed data on 245 consecutive HF admissions to a community hospital for whom total blood volume (TBV), red blood...